A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions

NCT06308419 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Leiomyosarcoma
Soft-tissue Sarcomas

Interventions

DRUG: Gemcitabine
DRUG: Nab-Sirolimus

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]